My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

5.200 -0.130 (-2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
Expert Ratings for AVITA Medical
 
Via Benzinga
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
From AVITA Medical
Via GlobeNewswire
Why Shares of Avita Medical Are Down Monday
The company's potential launch of a new device will likely be pushed back. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations. 
Via Benzinga
Analyst Expectations for AVITA Medical's Future
 
Via Benzinga
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Participate in Upcoming Investor Conferences
From AVITA Medical
Via GlobeNewswire
Expert Ratings for AVITA Medical
 
Via Benzinga
7 Analysts Have This to Say About AVITA Medical
 
Via Benzinga
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose... 
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 7/25
Via Investor Brand Network
AVITA Medical to Announce Second Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 7/13
Via Investor Brand Network
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to... 
Via Benzinga
AVITA Medical Submits FDA PMA Supplement for RECELL GO
From AVITA Medical
Via GlobeNewswire
Skin Grafts Disruption: Avita Medical's Regenerative Medicine System Poised to Disrupt Traditional Skin Grafts, Says Analyst
Cantor Fitzgerald has initiated coverage on Avita Medical Inc (NASDAQ: RCEL) at an Overweight rating and  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
 
Via Benzinga
AVITA Medical Rejoins the Russell 3000 Index
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.